Percheron Therapeutics (PERCF) Ratios
Percheron Therapeutics Ratios
PERCF's free cash flow for Q4 2026 was $-2.35M. For the 2026 fiscal year, PERCF's free cash flow was decreased by $-4.36K and operating cash flow was $-2.35M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.64 | 5.10 | 2.81 | 4.51 | 19.14 |
| Quick Ratio | 7.64 | 5.10 | 2.81 | 4.51 | 19.14 |
| Cash Ratio | 3.69 | 4.18 | 2.30 | 3.90 | 16.57 |
| Solvency Ratio | -6.61 | -6.11 | -2.29 | -3.94 | -4.42 |
| Operating Cash Flow Ratio | -7.17 | -6.43 | -1.96 | -2.90 | -6.72 |
| Short-Term Operating Cash Flow Coverage | -178.55 | 0.00 | -253.70 | -86.64 | -82.95 |
| Net Current Asset Value | $ 4.59M | $ 9.97M | $ 9.31M | $ 9.82M | $ 20.92M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.09 | 1.24 | 1.55 | 1.29 | 1.06 |
| Debt Service Coverage Ratio | -109.08 | -993.77 | -218.14 | -114.15 | -54.19 |
| Interest Coverage Ratio | -366.34 | -1118.94 | -4129.92 | -1636.62 | -639.17 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.47 | 0.62 | 1.00 | 0.82 | 2.53 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 87.31% | 91.26% | 83.52% | 87.81% | 76.57% |
| EBT Per EBIT | 97.65% | 97.87% | 95.91% | 97.11% | 99.72% |
| Return on Assets (ROA) | -58.27% | -119.99% | -82.03% | -88.61% | -25.90% |
| Return on Equity (ROE) | -63.63% | -149.16% | -127.30% | -114.08% | -27.49% |
| Return on Capital Employed (ROCE) | -74.63% | -167.02% | -158.67% | -133.04% | -35.77% |
| Return on Invested Capital (ROIC) | -64.92% | -152.02% | -131.40% | -114.67% | -27.15% |
| Return on Tangible Assets | -90.00% | -119.99% | -82.03% | -88.61% | -25.90% |
| Earnings Yield | -136.17% | -145.71% | -22.27% | -28.83% | -15.53% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 1.20 | 0.05 | 0.02 | 0.09 | 0.27 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -303.66 | -7681.11 | -17134.76 | -3921.56 | -1355.81 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 303.66 | 7681.11 | 17134.76 | 3921.56 | 1355.81 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.02 | -0.02 | -0.01 | -0.01 |
| Free Cash Flow Per Share | -0.00 | -0.02 | -0.02 | -0.01 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | -625.22 | -2160.68 | -2805.28 | -278.29 | -1994.68 |
| Capital Expenditure Coverage Ratio | -625.22 | -2160.68 | -2805.28 | -278.29 | -1994.68 |
| Operating Cash Flow Coverage Ratio | -178.55 | -604.81 | -253.70 | -57.36 | -34.32 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -141.21% | -152.82% | -18.91% | -20.72% | -20.87% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.73 | -0.68 | -4.49 | -3.47 | -6.44 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.47 | 1.02 | 5.72 | 3.96 | 1.77 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.71 | -0.65 | -5.29 | -4.83 | -4.79 |
| Price-to-Operating Cash Flow Ratio | -0.71 | -0.65 | -5.29 | -4.84 | -4.79 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.04 | -0.95 | -0.04 | 0.17 |
| Enterprise Value Multiple | -0.18 | -0.01 | -3.52 | -2.16 | -2.45 |
| Enterprise Value | 994.40K | 98.96K | 41.70M | 28.65M | 18.42M |
| EV to EBITDA | -0.18 | -0.01 | -3.52 | -2.16 | -2.45 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -0.20 | -0.01 | -4.12 | -3.50 | -2.36 |
| EV to Operating Cash Flow | -0.20 | -0.01 | -4.12 | -3.51 | -2.36 |
| Tangible Book Value Per Share | 0.00 | 0.01 | 0.01 | 0.01 | 0.03 |
| Shareholders’ Equity Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.13 | 0.09 | 0.16 | 0.12 | 0.23 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.01 | -0.02 | -0.02 | -0.01 |
| Tax Burden | 0.87 | 0.91 | 0.84 | 0.88 | 0.77 |
| Interest Burden | 0.98 | 1.00 | 1.20 | 0.97 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.04 | 1.05 | 0.85 | 0.72 | 1.34 |
Currency in AUD